|
|
|
Article Cited by others ORIGINAL ARTICLE
A retrospective clinical study of bevacizumab combined with gemcibabine or paclitaxel in the treatment of recurrent ovarian cancer
Wu M D, Wang Y, Ding T, Zhou Y F, Song J, Liu X H, Wei M H, Yang Q H, Zhou J, Wang S H, Lv Q Y
Year : 2014| Volume: 51| Issue : 7 | Page no: 103-105 | This article has been cited by | | 1 |
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis |
|
| | Kazuki Takasaki,Morikazu Miyamoto,Masashi Takano,Hiroaki Soyama,Tadashi Aoyama,Hiroko Matsuura,Kento Kato,Takahiro Sakamoto,Mika Kuwahara,Hideki Iwahashi,Hiroki Ishibashi,Tomoyuki Yoshikawa,Kenichi Furuya | | | Cancer Chemotherapy and Pharmacology. 2018; 81(5): 809 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Platinum-resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine |
|
| | Shinichi Komiyama,Tsuyoki Kugimiya,Chiaki Takeya,Rena Takahashi,Kaneyuki Kubushiro | | | Journal of Obstetrics and Gynaecology Research. 2018; 44(7): 1330 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
